pyrrolidine dithiocarbamate has been researched along with Anoxia-Ischemia, Brain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Peng, S; Wang, Z; Zhao, H; Zuo, Z | 1 |
Ahtoniemi, T; Goldsteins, G; Gröhn, O; Koistinaho, J; Närväinen, J; Nurmi, A; Pihlaja, R | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Anoxia-Ischemia, Brain
Article | Year |
---|---|
Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia-ischemia in neonatal rats.
Topics: Administration, Intranasal; Animals; Animals, Newborn; Brain; Dose-Response Relationship, Drug; Female; Hypoxia-Ischemia, Brain; Inflammation Mediators; Male; Neuroprotective Agents; Pyrrolidines; Random Allocation; Rats; Rats, Sprague-Dawley; Thiocarbamates | 2013 |
Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Blotting, Western; Electrophoresis, Polyacrylamide Gel; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypoxia-Ischemia, Brain; Immunohistochemistry; Magnetic Resonance Imaging; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Pyrrolidines; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Thiocarbamates | 2006 |